The US medical cannabis industry is in a difficult position, conceptually straddling the line between recreational use and pharmaceutical drug development.
Editorial
If living through the COVID-19 pandemic has taught me anything, it has been to embrace change and the unknown. With great enthusiasm and promise, I now find myself in a new position as Editor in Chief at the American Journal of Endocannabinoid Medicine. Over the past few years, the journal has been a reputable place…
I am, if nothing else, a champion of women and have been so my entire career, including in my current role in the medical cannabis field as well as in my 18 years as a board-certified obstetrician and gynecologist (OB/GYN). Co-founding the female-owned medical cannabis dispensary, Greenhouse Wellness, and developing female-focused medical cannabis products are…
We are entering a time in the cannabis industry when research and accurate reporting of scientific outcomes are becoming increasingly important. The field is facing competition from unlikely sources.
The long history of cannabis in women’s medicine supports further study.
“There is no research on cannabis” is a myth conception frequently encountered. Yet, while stating there is no research on cannabis, many sources are still willing to infer causality and contend that cannabis is both the cause of and answer to various health problems.
